Identification of a Novel, Potent, and Orally Bioavailable Oxadiazole-Based Sphingosine Kinases Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of Prostatic Cancer

Tong Li, Xiujuan Shi, Zhiqiang Qu, Haiyang Wang, Feng Huang, Junru Liu, Xiaoqing Xu, Cong Lin, H.h. Li, Xi Qiu, Zhaoyang Li, Yuanyuan Liu, Yuqi Gao, Xiaodong Zhao, Yanling Mu, Qingqiang Yao, Zhengguo Cui, Feipeng Zhang, Tiandi Ding, Xuerui Zhang, Bo LiuSSRN 2024 · DOI

BibTeX
@misc{li2024identification,
  author = {Tong Li and Xiujuan Shi and Zhiqiang Qu and Haiyang Wang and Feng Huang and Junru Liu and Xiaoqing Xu and Cong Lin and H.H. Li and Xi Qiu and Zhaoyang Li and Yuanyuan Liu and Yuqi Gao and Xiaodong Zhao and Yanling Mu and Qingqiang Yao and Zhengguo Cui and Feipeng Zhang and Tiandi Ding and Xuerui Zhang and Bo Liu},
  title = {{Identification of a Novel, Potent, and Orally Bioavailable Oxadiazole-Based Sphingosine Kinases Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of Prostatic Cancer}},
  year = {2024},
  doi = {10.2139/ssrn.5051274},
  howpublished = {SSRN},
}

Loading related content...

Figure